.
MergerLinks Header Logo

New Deal


Announced

Royal DSM to acquire the flavor and fragrance bio-based intermediates business from Amyris for $150m.

Financials

Edit Data
Transaction Value£109m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

United States

Cross Border

fragrance & flavor

Acquisition

Friendly

Majority

Specialty Chemicals

Single Bidder

Pending

Synopsis

Edit

Royal DSM, a global, purpose-led, science-based company, agreed to acquire the flavor and fragrance bio-based intermediates business from Amyris, a firm that produces and distributes chemical products, for $150m. “We are pleased that we can extend the offering to our customers with an additional seven important intermediates that will help our flavor and fragrance and cosmetics customers to improve their sustainability profile. These bio-based ingredients provide them with attractive and sustainable additional alternatives," Gareth Barker, DSM President of Personal Care & Aroma Ingredients.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US